[Elsevier] Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial

myyoyolin Post time 2024-5-3 10:30:53 | Show all posts |Read mode
Reward10points

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00356-X/abstract

Thanks!

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
zpsukhan Post time 2024-5-3 10:30:54 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    810

Latest Reply

Return to the list